Insider Transactions in Q3 2025 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2025
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-1.29%
|
-
|
|
Sep 01
2025
|
Richard Byrd EVP & President Interventional |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-3.11%
|
-
|
|
Aug 22
2025
|
Michael Feld EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct |
57
-0.68%
|
$11,229
$197.99 P/Share
|
|
Aug 20
2025
|
Michael Feld EVP & President, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
773
-8.41%
|
-
|
|
Aug 11
2025
|
Gregory Hayes Director |
BUY
Open market or private purchase
|
Direct |
5,250
+46.48%
|
$1,002,750
$191.57 P/Share
|
|
Aug 08
2025
|
Claire Fraser Director |
SELL
Open market or private sale
|
Direct |
863
-3.59%
|
$165,696
$192.3 P/Share
|
|
Jul 18
2025
|
Michael David Garrison EVP & President, Medical |
SELL
Open market or private sale
|
Direct |
1,185
-9.76%
|
$213,300
$180.89 P/Share
|
|
Jul 18
2025
|
Michael David Garrison EVP & President, Medical |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,175
-46.01%
|
$931,500
$180.29 P/Share
|
|
Jul 18
2025
|
Michael David Garrison EVP & President, Medical |
BUY
Exercise of conversion of derivative security
|
Direct |
6,360
+36.12%
|
$934,920
$147.68 P/Share
|
|
Jul 02
2025
|
Bilal Muhsin EVP & President Connected Care |
BUY
Grant, award, or other acquisition
|
Direct |
12,221
+50.0%
|
-
|